Clinical Trial

ColoSeal™ ICD System Anastomotic Protection Pivotal Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this clinical investigation is to evaluate the safety of the ColoSeal ICD System by evaluating its effectiveness in reducing the stoma creation rate and by comparing the rate of major complications to current standard of care for rectal cancer surgery with a diverting ostomy.
Trial Details
NCT Number NCT07429110
Lead Sponsor Averto Medical, Inc.
Collaborators: National Cancer Institute (NCI)
Conditions Rectal Cancer Surgery
Enrollment 250 participants
Start Date 2026-04
Primary Completion 2028-02 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-02-24